CN105985967A - Biosynthetic gene cluster of oosporein and application of biosynthetic gene cluster - Google Patents
Biosynthetic gene cluster of oosporein and application of biosynthetic gene cluster Download PDFInfo
- Publication number
- CN105985967A CN105985967A CN201510070362.2A CN201510070362A CN105985967A CN 105985967 A CN105985967 A CN 105985967A CN 201510070362 A CN201510070362 A CN 201510070362A CN 105985967 A CN105985967 A CN 105985967A
- Authority
- CN
- China
- Prior art keywords
- oosporein
- gene
- gene cluster
- ops1
- ops3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DHMPJEGFPQTNFX-UHFFFAOYSA-N 2-(2,5-dihydroxy-4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-3,6-dihydroxy-5-methylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C(C)=C(O)C(=O)C(C=2C(C(O)=C(C)C(=O)C=2O)=O)=C1O DHMPJEGFPQTNFX-UHFFFAOYSA-N 0.000 title claims abstract description 316
- 108091008053 gene clusters Proteins 0.000 title claims abstract description 53
- 230000001851 biosynthetic effect Effects 0.000 title abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 108
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 99
- 101100188716 Beauveria bassiana (strain ARSEF 2860) OpS1 gene Proteins 0.000 claims abstract description 78
- 101100188727 Beauveria bassiana (strain ARSEF 2860) OpS3 gene Proteins 0.000 claims abstract description 76
- 101100188732 Beauveria bassiana (strain ARSEF 2860) OpS4 gene Proteins 0.000 claims abstract description 56
- 241000751139 Beauveria bassiana Species 0.000 claims abstract description 55
- 101100242167 Beauveria bassiana (strain ARSEF 2860) OpS7 gene Proteins 0.000 claims abstract description 53
- 101100242163 Beauveria bassiana (strain ARSEF 2860) OpS5 gene Proteins 0.000 claims abstract description 46
- 101100242165 Beauveria bassiana (strain ARSEF 2860) OpS6 gene Proteins 0.000 claims abstract description 39
- 101100188722 Beauveria bassiana (strain ARSEF 2860) OpS2 gene Proteins 0.000 claims abstract description 26
- AMKYESDOVDKZKV-UHFFFAOYSA-N o-orsellinic acid Chemical compound CC1=CC(O)=CC(O)=C1C(O)=O AMKYESDOVDKZKV-UHFFFAOYSA-N 0.000 claims description 76
- 238000003786 synthesis reaction Methods 0.000 claims description 62
- 238000000034 method Methods 0.000 claims description 44
- 210000004027 cell Anatomy 0.000 claims description 31
- 229940125782 compound 2 Drugs 0.000 claims description 24
- 108010030975 Polyketide Synthases Proteins 0.000 claims description 22
- 230000014509 gene expression Effects 0.000 claims description 21
- 239000002773 nucleotide Substances 0.000 claims description 21
- 125000003729 nucleotide group Chemical group 0.000 claims description 21
- 108010074633 Mixed Function Oxygenases Proteins 0.000 claims description 17
- 102000008109 Mixed Function Oxygenases Human genes 0.000 claims description 17
- LMODBTYAMBSWQE-UHFFFAOYSA-N (2-hydroxyphenyl)methanetriol Chemical compound OC1=CC=CC=C1C(O)(O)O LMODBTYAMBSWQE-UHFFFAOYSA-N 0.000 claims description 14
- 108010000912 Egg Proteins Proteins 0.000 claims description 14
- 102000002322 Egg Proteins Human genes 0.000 claims description 14
- 150000001413 amino acids Chemical class 0.000 claims description 14
- 101150036080 at gene Proteins 0.000 claims description 14
- 210000004681 ovum Anatomy 0.000 claims description 14
- 108091023040 Transcription factor Proteins 0.000 claims description 13
- 108700005078 Synthetic Genes Proteins 0.000 claims description 12
- 102000040945 Transcription factor Human genes 0.000 claims description 12
- 235000001014 amino acid Nutrition 0.000 claims description 12
- 239000013604 expression vector Substances 0.000 claims description 12
- 239000002243 precursor Substances 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 101001015517 Betula pendula Germin-like protein 1 Proteins 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 108010029541 Laccase Proteins 0.000 claims description 9
- 101710085061 Orsellinic acid synthase Proteins 0.000 claims description 9
- 108010078791 Carrier Proteins Proteins 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 102000014914 Carrier Proteins Human genes 0.000 claims description 7
- 229960003180 glutathione Drugs 0.000 claims description 7
- 239000007858 starting material Substances 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 239000012634 fragment Substances 0.000 claims description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 6
- 235000003969 glutathione Nutrition 0.000 claims description 6
- 210000000349 chromosome Anatomy 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 230000008676 import Effects 0.000 claims description 3
- 238000005259 measurement Methods 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 18
- 230000006870 function Effects 0.000 abstract description 12
- 230000000749 insecticidal effect Effects 0.000 abstract description 5
- 238000004458 analytical method Methods 0.000 abstract description 4
- 230000002068 genetic effect Effects 0.000 abstract description 3
- 238000010367 cloning Methods 0.000 abstract description 2
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 238000012163 sequencing technique Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 52
- 238000000855 fermentation Methods 0.000 description 50
- 230000004151 fermentation Effects 0.000 description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- 241000894006 Bacteria Species 0.000 description 27
- 239000001963 growth medium Substances 0.000 description 25
- 102000040430 polynucleotide Human genes 0.000 description 25
- 108091033319 polynucleotide Proteins 0.000 description 25
- 239000002157 polynucleotide Substances 0.000 description 25
- 239000000243 solution Substances 0.000 description 25
- 230000008569 process Effects 0.000 description 23
- 238000004128 high performance liquid chromatography Methods 0.000 description 18
- 125000003275 alpha amino acid group Chemical group 0.000 description 17
- 229940125904 compound 1 Drugs 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 14
- 229920001184 polypeptide Polymers 0.000 description 14
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 239000006228 supernatant Substances 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 241000235061 Pichia sp. Species 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 241000255896 Galleria mellonella Species 0.000 description 11
- 238000009825 accumulation Methods 0.000 description 11
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 230000000295 complement effect Effects 0.000 description 9
- 150000002576 ketones Chemical group 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 125000000539 amino acid group Chemical group 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 229940126214 compound 3 Drugs 0.000 description 8
- 230000008034 disappearance Effects 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- 241000589158 Agrobacterium Species 0.000 description 7
- 238000006555 catalytic reaction Methods 0.000 description 7
- 230000002147 killing effect Effects 0.000 description 7
- 244000045947 parasite Species 0.000 description 7
- CCDXIADKBDSBJU-UHFFFAOYSA-N phenylmethanetriol Chemical compound OC(O)(O)C1=CC=CC=C1 CCDXIADKBDSBJU-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 101001120937 Beauveria bassiana (strain ARSEF 2860) Oxidoreductase OpS5 Proteins 0.000 description 6
- 108010006654 Bleomycin Proteins 0.000 description 6
- 101100184662 Caenorhabditis elegans mogs-1 gene Proteins 0.000 description 6
- 101150014754 OpS1 gene Proteins 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 6
- 229960001561 bleomycin Drugs 0.000 description 6
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 238000000825 ultraviolet detection Methods 0.000 description 6
- 241000224979 Beauveria bassiana ARSEF 2860 Species 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 101150003733 OpS5 gene Proteins 0.000 description 5
- 101150057682 OpS7 gene Proteins 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000006114 decarboxylation reaction Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000005611 electricity Effects 0.000 description 5
- 238000005805 hydroxylation reaction Methods 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 4
- 102000010909 Monoamine Oxidase Human genes 0.000 description 4
- 108010062431 Monoamine oxidase Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 229960004756 ethanol Drugs 0.000 description 4
- 230000000640 hydroxylating effect Effects 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 101150069398 OpS2 gene Proteins 0.000 description 3
- 101150009068 OpS3 gene Proteins 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000001408 fungistatic effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000013067 intermediate product Substances 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012797 qualification Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 244000153158 Ammi visnaga Species 0.000 description 2
- 235000010585 Ammi visnaga Nutrition 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 101100518462 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) orsA gene Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 102000005720 Glutathione transferase Human genes 0.000 description 2
- 108010070675 Glutathione transferase Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000007836 KH2PO4 Substances 0.000 description 2
- 241001506991 Komagataella phaffii GS115 Species 0.000 description 2
- 101001031591 Mus musculus Heart- and neural crest derivatives-expressed protein 2 Proteins 0.000 description 2
- 101150117891 OpS6 gene Proteins 0.000 description 2
- 241000005308 Orsa Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 108010070996 Salicylate 1-monooxygenase Proteins 0.000 description 2
- 241001655322 Streptomycetales Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 2
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000006471 dimerization reaction Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229910052564 epsomite Inorganic materials 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 238000003209 gene knockout Methods 0.000 description 2
- 238000003208 gene overexpression Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003677 hemocyte Anatomy 0.000 description 2
- 229940000351 hemocyte Drugs 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- LTYOQGRJFJAKNA-IJCONWDESA-N malonyl-coenzyme a Chemical compound O[C@@H]1[C@@H](OP(O)(O)=O)[C@H](CO[P@](O)(=O)O[P@@](O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-IJCONWDESA-N 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 150000004053 quinones Chemical class 0.000 description 2
- 238000010010 raising Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000002909 Aspergillosis Diseases 0.000 description 1
- 208000036641 Aspergillus infections Diseases 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000223679 Beauveria Species 0.000 description 1
- WTEJQBARPJSNLZ-UHFFFAOYSA-N C(C(=O)N)(=O)O.P Chemical compound C(C(=O)N)(=O)O.P WTEJQBARPJSNLZ-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- JDMUPRLRUUMCTL-VIFPVBQESA-N D-pantetheine 4'-phosphate Chemical compound OP(=O)(O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS JDMUPRLRUUMCTL-VIFPVBQESA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- NGWKGSCSHDHHAJ-YPFQVHCOSA-N Liquoric acid Chemical compound C1C[C@H](O)C(C)(C)C2CC[C@@]3(C)[C@]4(C)C[C@H]5O[C@@H]([C@](C6)(C)C(O)=O)C[C@@]5(C)[C@@H]6C4=CC(=O)C3[C@]21C NGWKGSCSHDHHAJ-YPFQVHCOSA-N 0.000 description 1
- NGWKGSCSHDHHAJ-UHFFFAOYSA-N Liquoric acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CC5OC(C(C6)(C)C(O)=O)CC5(C)C6C4=CC(=O)C3C21C NGWKGSCSHDHHAJ-UHFFFAOYSA-N 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 108700005443 Microbial Genes Proteins 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- 102000006833 Multifunctional Enzymes Human genes 0.000 description 1
- 108010047290 Multifunctional Enzymes Proteins 0.000 description 1
- 229910004619 Na2MoO4 Inorganic materials 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 229940087098 Oxidase inhibitor Drugs 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 244000173166 Pyrus ussuriensis Species 0.000 description 1
- 235000011572 Pyrus ussuriensis Nutrition 0.000 description 1
- 240000000203 Salix gracilistyla Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical class [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 102000012463 Thioesterase domains Human genes 0.000 description 1
- 108050002018 Thioesterase domains Proteins 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 208000026487 Triploidy Diseases 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- 208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 241000317299 bacterium AgL1 Species 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000011953 bioanalysis Methods 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000007622 bioinformatic analysis Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 description 1
- 229960000603 cefalotin Drugs 0.000 description 1
- 229910052927 chalcanthite Inorganic materials 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000004050 enoyl group Chemical group 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 101150073906 gpdA gene Proteins 0.000 description 1
- 101150095733 gpsA gene Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- -1 hydrogen Potassium oxide Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052603 melanterite Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 101150114168 ops gene Proteins 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012313 reversal agent Substances 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000011091 sodium acetates Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to a biosynthetic gene cluster of oosporein, in particular to cloning, sequencing, analysis and function studies of the oosporein biosynthetic gene cluster which is produced from beauveria bassiana and has insecticidal and antimicrobial functions as well as an application of the oosporein biosynthetic gene cluster. Totally, the entire gene cluster includes seven genes, namely OpS1, OpS2, OpS3, OpS4, OpS5, OpS6 and OpS7. By conducting a genetic operation the biosynthetic genes, the bio-synthesis of the oosporein can be blocked, or the yield of the oosporein can be changed or a new compound can be generated. The invention also discovers a bio-synthesis way of the oosporein for the first time, and the invention has an important research significance.
Description
Technical field
The invention belongs to microbial gene resource and genetic engineering field, be specifically related to that there is parasite killing and antibacterial work
The clone of biological synthesis gene cluster, analysis, functional study and the application thereof of oosporein.
Background technology
Oosporein (Oosporein) is initially the sixties in last century, and qualification is a kind of by beauveria bassiana
(Beauveria bassiana) and muscardine (Beauveria brongniarti) produce outside born of the same parents
Red pigments, there is certain insecticidal activity and bacteriostasis.The activity of monoamine oxidase, MAO (MAO) is different
Often can cause body several functions obstacle, form morbid state, such as parkinson, senile dementia and near
Depressions the most popular in city over Nian etc. are all relevant with MAO activity exception, and oosporein is as a class
Oxidase inhibitor, has due to the abnormal disease related drugs caused of monoamine enzymatic activity possibly for research and development
Certain help.Although oosporein early has been observed that at present, and has resolved its structure (Fig. 1), but
The biosynthesis pathway of oosporein is the most unclear.
Therefore, we are with microbe-derived oosporein as target molecule, from the biology of clone's oosporein
Synthetic gene bunch sets out, and uses microbiology, molecular biology, biochemistry and organic chemistry to combine
Method study its biosynthesis, explore its biosynthesis pathway and regulatory mechanism, and verify oosporein
Parasite killing and fungistatic effect.
Summary of the invention
The present invention relates to have the biological synthesis gene cluster of the oosporein of insecticidal and antifungal effect clone, point
Analysis, functional study and application thereof.
A first aspect of the present invention provides the biological synthesis gene cluster of a kind of oosporein, and described gene cluster includes
The coding 7 oosporein synthesis related gene: OpS1 involved by oosporein biosynthesis, OpS2, OpS3,
OpS4、OpS5、OpS6、OpS7;
Wherein, OpS1 is positioned at gene cluster nucleotide sequence 24759-32012 position, encodes polyketide synthase/orsellinic acid
Synthase, a length of 2211 aminoacid;
OpS2 is positioned at gene cluster nucleotide sequence 32992-34102 position, encodes transport protein, and a length of 350
Individual aminoacid;
OpS3 is positioned at gene cluster nucleotide sequence 36584-38809 position, encoding transcription factors, and a length of 741
Individual aminoacid;
OpS4 is positioned at gene cluster nucleotide sequence 39149-40901 position, encoding hydroxylase, a length of 427 ammonia
Base acid;
OpS5 is positioned at gene cluster nucleotide sequence 41885-44041 position, encoding laccases, a length of 590 amino
Acid;
OpS6 is positioned at gene cluster nucleotide sequence 44430-45147 position, coding for glutathion S transferring enzyme, length
It is 218 aminoacid;
OpS7 is positioned at gene cluster nucleotide sequence 45713-46768 position, encodes Cupin albumen, and a length of 305
Individual aminoacid.
In another preference, the sequence of described gene cluster is 8391-54012 position in SEQ ID NO.1.
In another preference, described gene cluster also includes in described 7 oosporein synthesis related genes
The base combining or being constituted that gene or multiple (such as 2,3,4,5,6 or 7) gene are constituted
Cause bunch or its fragment.
Second aspect present invention provides the biosynthesis associated protein of a kind of oosporein, the amino of described albumen
Acid sequence is selected from the aminoacid sequence as shown in SEQ ID NO.:2-8.
In another preference, described biosynthesis associated protein is the polyketide synthase shown in SEQ ID NO.:2
/ orsellinic acid synthase.
In another preference, described biosynthesis associated protein is the transport protein shown in SEQ ID NO.:3.
In another preference, described biosynthesis associated protein is the transcription factor shown in SEQ ID NO.:4.
In another preference, described biosynthesis associated protein is the hydroxylase shown in SEQ ID NO.:5.
In another preference, described biosynthesis associated protein is the laccase shown in SEQ ID NO.:6.
In another preference, described biosynthesis associated protein is the glutathion shown in SEQ ID NO.:7
Transferring enzyme.
In another preference, described biosynthesis associated protein is the Cupin albumen shown in SEQ ID NO.:8.
Third aspect present invention provides the biosynthesis related genes of a kind of oosporein, and described gene code is originally
The biosynthesis associated protein of oosporein described in invention second aspect.
In another preference, described biosynthesis related genes is selected from following gene:
OpS1, OpS2, OpS3, OpS4, OpS5, OpS6, OpS7 or a combination thereof.
In another preference, the information of the nucleotide sequence of described synthesis related gene as mentioned above or is shown in Table 1.
Fourth aspect present invention provides a kind of expression vector, and described expression vector contains first aspect present invention institute
The biological synthesis gene cluster of the oosporein stated or its fragment, or the life of the oosporein described in third aspect present invention
Thing synthesis related gene.
Fifth aspect present invention provides the host cell of a kind of restructuring, and described host cell contains the present invention the 4th
Integrate on expression vector described in aspect, or its chromosome and have the oosporein described in first aspect present invention of external source
Biological synthesis gene cluster or third aspect present invention described in the biosynthesis related genes of oosporein.
In another preference, the host cell of described restructuring includes eukaryotic cell, such as beauveria bassiana, finishes
Red yeast.
Sixth aspect present invention provides a kind of beauveria bassiana (Beauveria bassiana), described
In beauveria bassiana, being lost selected from lower group of one or more genes in the biological synthesis gene cluster of oosporein
Live: OpS1, OpS3, OpS4, OpS5, OpS6, OpS7, thus do not produce oosporein.
In another preference, described it is deactivated the gene that gene is selected from lower group: OpS1, OpS3,
OpS4, OpS5, OpS6, and OpS7.
In another preference, in described beauveria bassiana, Ops2 gene is retained.
Seventh aspect present invention provides a kind of beauveria bassiana (Beauveria bassiana), described ball
In beauveria bassiana, in the biological synthesis gene cluster of oosporein, one or more genes are over-expressed, thus carry
Height or the yield of recovery oosporein,
Wherein, the described gene that is over-expressed is selected from lower group: OpS1, OpS3, OpS4, OpS5, OpS6
And OpS7.
In another preference, in described beauveria bassiana, Ops2 gene is knocked or lowers.
In another preference, described raising refers to, produces with the oosporein of original strain (beauveria bassiana)
Amount A0 compares, and oosporein yield A1 in the beauveria bassiana of described process LAN is >=1.5 with the ratio of A0,
Preferably >=2.0, more preferably >=2.5, such as 1.5-10, preferably 2-5.
Eighth aspect present invention provides the purposes of a kind of oosporein biosynthesis gene or its albumen, is used for
The precursor of synthesis oosporein or intermediate, wherein said oosporein biosynthesis gene or the choosing of its albumen
From lower group: OpS1, OpS4, OpS5, OpS7.
In another preference, described synthesizes external enzyme' s catalysis or synthetic.
In another preference, it is provided that a kind of OpS1 gene or the purposes of its albumen, described OpS1 gene
Or its albumen is for synthesizing the synthesis precursor of oosporein.
In another preference, the synthesis precursor of described oosporein is orsellinic acid.
In another preference, shown OpS1 gene or its albumen are with S-acetyl-coenzyme-A for catalytic material glycosides color
The synthesis of acid.
In another preference, the structure of described orsellinic acid shown in formula I:
In another preference, it is provided that a kind of OpS4 gene or the purposes of its albumen, described OpS4 gene
Or its albumen is for the decarboxylation hydroxylation reaction of catalysis type I, thus generate Formula II intermediate.
In another preference, described intermediate is compound 2.
In another preference, described compound 2 is trihydroxytoluene.
In another preference, the structure of described compound 2 is as shown in Formula II:
In another preference, described compound 2 structural instability, compound 3 can be partially converted into and change
Compound 4.
In another preference, described compound 3 is ketone form structure, and its structure is as shown in formula III:
In another preference, shown compound 4 is formed by the oxidation polymerization of 2 compounds 2, and its structure is such as
Shown in formula IV:
In another preference, it is provided that a kind of OpS7 gene or the purposes of its albumen, described OpS7 gene or
Its albumen, for being catalyzed the hydroxylation reaction of Formula II compound, generates tetrahydroxy toluene.
In another preference, the structure of described tetrahydroxy toluene shown as a formula V:
In another preference, described tetrahydroxy toluene structural instability, compound 1 can be partially converted into.
In another preference, described compound 1 is ketone form structure, and its structure is as shown in Formula IV:
In another preference, it is provided that a kind of OpS5 gene or the purposes of its albumen, described OpS5 gene or
Its albumen, for being catalyzed the oxidative polymerization of tetrahydroxy toluene, produces oosporein.
In another preference, the structure of described oosporein is as shown in Formula VII:
Ninth aspect present invention provides a kind of method preparing ooecium mycin, including step:
I (), in the condition of applicable cultivation and in the case of adding starting compound, is cultivated and is produced ooecium mycin
Host cell, thus produce ooecium mycin, wherein said starting compound is selected from lower group: orsellinic acid (Formulas I),
Compound 2 (Formula II), tetrahydroxy toluene (Formula V) or a combination thereof;With
(ii) isolated or purified goes out described ooecium mycin.
In another preference, described host cell is beauveria bassiana.
In another preference, described host cell is introduced into the ball spore of external source ooecium mycin synthesis related gene
Muscardine, wherein said gene is selected from lower group: OpS1, OpS3, OpS4, OpS5, OpS6 or OpS7 base
Cause.
Tenth aspect present invention provides a kind of method transforming host cell, including step:
(a) measure each related gene belonging to ooecium mycin synthetic gene bunch in described host cell expression and/or
Activity;
B (), according to measurement result, imports the related gene of ooecium mycin synthetic gene bunch in described host cell,
Thus improve/recover described host cell and produce the ability of ooecium mycin,
Wherein, the related gene of described gene cluster include one or more following gene: OpS1, OpS3, OpS4,
OpS5, OpS6 or OpS7.
In another preference, described host cell is beauveria bassiana.
In another preference, when OpS1 gene inactivation or the activity decrease of described gene cluster, further comprise the steps of:
Adding starting compound in cultivating system, described starting compound is selected from lower group: orsellinic acid (Formulas I),
Compound 2 (Formula II), tetrahydroxy toluene (Formula V) or a combination thereof, to recover the formation of ooecium mycin.
The present invention the 11st aspect provides a kind of compound relevant to ooecium mycin, and described compound is selected from down
Group:
Compound 2 (Formula II), compound 3 (formula III), compound 4 (formula IV) and compound 1 (Formula IV).
The twelfth aspect of the present invention provides a kind of method of ability improving beauveria bassiana generation ooecium mycin, bag
Include step:
In described beauveria bassiana, import the related gene of ooecium mycin synthetic gene bunch, thus improve or recover
Described beauveria bassiana produce ooecium mycin ability, wherein, the related gene of described gene cluster include one or
Multiple following gene: OpS1, OpS3, OpS4, OpS5, OpS6 or OpS7;Or
Knock out the OpS2 gene of ooecium mycin synthetic gene bunch in described beauveria bassiana, thus improve described ball
Beauveria bassiana produces the ability of ooecium mycin.
The present invention the 13rd aspect provides OpS2 polypeptide or the purposes of its encoding gene of a kind of separation, institute
State OpS2 polypeptide or gene for suppressing the synthesis of oosporein.
In another preference, described OpS2 polypeptide is selected from lower group: (i) has amino shown in SEQ ID NO:3
The polypeptide of acid sequence;
(ii) by SEQ ID NO:3 aminoacid sequence through the replacement of one or several amino acid residue, disappearance
Or add and formed and have suppression ooecium rhzomorph complex functionality the polypeptide derivative by (i).
In another preference, the coded sequence of described OpS2 polypeptide is selected from lower group:
(1) coding polynucleotide sequence of polypeptide as described in SEQ ID NO:3;
(2) polynucleotide sequence as shown in SEQ ID NO:10;
(3) polynucleotide that the polynucleotide sequence and described in (1) or (2) is complementary.
Fourteenth aspect of the present invention provides the biosynthesis base of oosporein described in a kind of first aspect present invention
Cause bunch or the purposes of its portion gene, it is characterised in that in described gene cluster, portion gene is used at ball spore
The mutant of muscardine ARSEF 2860 related gene disappearance carries out allos complementary, thus recover to produce ovum
P0-357;Or portion gene in described gene cluster is carried out heterogenous expression in Pichia sp., thus produce ovum
The synthesis precursor of p0-357, intermediate and oosporein analog.
In another preference, described Pichia sp. is selected from GS115.
In another preference, the synthesis precursor of described oosporein is orsellinic acid (Formulas I).
In another preference, the synthetic intermediate of described oosporein is compound 2 (Formula II), chemical combination
Thing 3 (formula III), tetrahydroxy toluene (Formula V) and compound 1 (Formula IV).
In another preference, described oosporein analog is compound 4 (formula IV).
In should be understood that within the scope of the present invention, above-mentioned each technical characteristic of the present invention and below (as implemented
Example) in can be combined with each other between each technical characteristic of specifically describing, thus constitute new or preferred skill
Art scheme.As space is limited, the most tired at this state.
Accompanying drawing explanation
Fig. 1 shows chemical structural formula and the color of oosporein.
Fig. 2 shows oosporein synthetic gene clustering architecture.
Fig. 3 shows OpS1 knockout carrier structure.
Fig. 4 shows each knock out mutants body and the change of wild-type strain fermentation liquid color.
Fig. 5 shows each mutant and wild-type strain fermentation liquid HPLC testing result.
Fig. 6 shows OpS3 over-express vector structure.
Fig. 7 shows that wild type, OpS3 knock out and process LAN mutant fermentation liquid color contrast.
Fig. 8 shows wild type and each mutant fermentation liquid HPLC testing result.
Fig. 9 shows wild-type strain and each mutant oosporein yield comparison.
Figure 10 shows the RT-PCR knot of wild-type strain and each mutant oosporein synthesis related gene
Really.
Figure 11 shows the domain composition contrast of OpS1 Yu OrSA.
Figure 12 shows that wild-type strain and Δ OpS1 mutant orsellinic acid feed experiment fermentation liquid color pair
Ratio.
Figure 13 shows that wild type and Δ OpS1 mutant orsellinic acid feed the HPLC testing result of experiment.
Figure 14 shows wild type and OpS1 heterogenous expression bacterial strain fermentation liquor and orsellinic acid standard specimen (OrA)
HPLC testing result.
Figure 15 shows wild-type strain and the color contrast of each mutants which had fermentation liquid.
Figure 16 shows wild type and each mutant fermentation liquid HPLC testing result.
Figure 17 shows wild type and mutant GS115::OpS4 fermentation liquid HPLC testing result.
Figure 18 shows " compound 1 " feeding trial HPLC of wild type and mutant Δ OpS7::OpS3
Testing result.
Figure 19 shows the route of synthesis of oosporein.
Figure 20 shows greater wax moth bioassay results.
Figure 21 shows the greater wax moth hemolymph microscopy result infected by muscardine.
Figure 22 shows that wild type and mutant infect the contrast of worm corpse.
Figure 23 shows oosporein bacteriostatic test.
Detailed description of the invention
The present inventor, through extensively in-depth study, divides with the oosporein in beauveria bassiana source for target
Son, from cloning its biological synthesis gene cluster in beauveria bassiana ARSEF 2860, uses micro-life
The technique study that thing, molecular biology, bioanalysis informatics, biochemistry and organic chemistry combine
Its biosynthesis, the first identified biological synthesis gene cluster of oosporein, specifically, described gene cluster bag
Include 7 genes, be respectively as follows: OpS1, OpS2, OpS3, OpS4, OpS5, OpS6, OpS7.Wherein, OpS1
Coding polyketide synthase/orsellinic acid synthase, OpS2 encode transport protein, OpS3 encoding transcription factors, OpS4
Encoding hydroxylase, OpS5 encoding laccases, OpS6 coding for glutathion S transferring enzyme, OpS7 encode Cupin
Albumen;Further, inventor is found that the biosynthesis pathway of oosporein first, and it is mould to demonstrate ovum spore
The parasite killing of element and fungistatic effect.On this basis, the present inventor completes the present invention.
Ooecium mycin synthesis related gene and albumen
As used herein, the invention discloses a kind of ooecium mycin synthetic gene bunch (gene cluster),
Described gene cluster includes: OpS1, OpS2, OpS3, OpS4, OpS5, OpS6, OpS7 gene.
Wherein, OpS1 gene code ketone synthase/orsellinic acid synthase, and OpS1 gene at least has selected from lower group
One or more features:
(i) coding aminoacid sequence as shown in SEQ ID NO:2;(ii) coding is such as SEQ ID NO:2
Shown aminoacid sequence replace through one or several amino acid residue, lack or add and formed by (i)
Derivative polypeptide;(iii) there is the polynucleotide sequence as shown in SEQ ID NO:9;(iv) have with such as
The polynucleotide that polynucleotide sequence shown in SEQ ID NO:9 is complementary.
OpS2 gene code transport protein, and OpS2 gene at least has the one or more spies selected from lower group
Levy: (i) coding aminoacid sequence as shown in SEQ ID NO:3;(ii) coding is such as SEQ ID NO:3
Shown aminoacid sequence replace through one or several amino acid residue, lack or add and formed by (i)
Derivative polypeptide;(iii) there is the polynucleotide sequence as shown in SEQ ID NO:10;(iv) have with
The polynucleotide that polynucleotide sequence shown in shown in SEQ ID NO:10 is complementary.
The OpS3 gene coding transcript factor, and OpS3 gene at least has the one or more spies selected from lower group
Levy: (i) coding aminoacid sequence as shown in SEQ ID NO:4;(ii) coding is such as SEQ ID NO:4
Shown aminoacid sequence replace through one or several amino acid residue, lack or add and formed by (i)
Derivative polypeptide;(iii) there is the polynucleotide sequence as shown in SEQ ID NO:11;(iv) have with
The polynucleotide that polynucleotide sequence shown in SEQ ID NO:11 is complementary.
OpS4 gene code hydroxylase;And OpS4 gene at least has one or more features selected from lower group:
(i) coding aminoacid sequence as shown in SEQ ID NO:5;(ii) coding is as shown in SEQ ID NO:5
Aminoacid sequence replace, lack or add through one or several amino acid residue and being spread out by (i) of being formed
Raw polypeptide;(iii) there is the polynucleotide sequence as shown in SEQ ID NO:12;(iv) have and SEQ
The polynucleotide that polynucleotide sequence shown in ID NO:12 is complementary.
OpS5 gene code laccase;And OpS5 gene at least has one or more features selected from lower group: (i)
Coding aminoacid sequence as shown in SEQ ID NO:6;(ii) coding ammonia as shown in SEQ ID NO:6
It is derivative by (i) that base acid sequence replaces through one or several amino acid residue, lack or adds and formed
Polypeptide;(iii) there is the polynucleotide sequence as shown in SEQ ID NO:13;(iv) have and SEQ ID NO:
The polynucleotide that polynucleotide sequence shown in 13 is complementary.
OpS6 gene code glutathione s-transferase;And OpS6 gene at least has selected from one of lower group or
Multiple features: (i) coding aminoacid sequence as shown in SEQ ID NO:7;(ii) coding is such as SEQ ID NO:
Aminoacid sequence shown in 7 replace through one or several amino acid residue, lack or add and formed by
I polypeptide that () is derivative;(iii) there is the polynucleotide sequence as shown in SEQ ID NO:14;(iv) have
The polynucleotide complementary with polynucleotide sequence shown in SEQ ID NO:14.
OpS7 gene code Cupin albumen;And OpS7 gene at least has the one or more spies selected from lower group
Levy: (i) coding aminoacid sequence as shown in SEQ ID NO:8;(ii) coding is such as SEQ ID NO:8
Shown aminoacid sequence replace through one or several amino acid residue, lack or add and formed by (i)
Derivative polypeptide;(iii) there is the polynucleotide sequence as shown in SEQ ID NO:15;(iv) have with
The polynucleotide that polynucleotide sequence shown in SEQ ID NO:15 is complementary.
In the case of the amino acid fragment having obtained ooecium mycin synthesis related gene, can construct according to it
Encode its nucleotide sequence, and design specific probe according to nucleotide sequence.Nucleotide full length sequence
Or its fragment generally can use the method for PCR TRAP, recombination method or synthetic to obtain.PCR is expanded
Increasing method, can design primer according to nucleotide sequence disclosed in this invention, especially open reading frame sequence,
And with commercially available cloud tints storehouse or the cloud tints storehouse as prepared by conventional method well known by persons skilled in the art as template,
Expand and obtain relevant sequence.When sequence is longer, it is often necessary to carry out twice or repeatedly PCR amplification, then
Again the fragment that each time amplifies is stitched together by proper order.
The determination of oosporein biological synthesis gene cluster
Inventor, on the basis of completing the order-checking of beauveria bassiana ARSEF 2860 strain gene group, passes through Gene
The method of Blast, have found gene orsA homologous genes OpS1 in beauveria bassiana and place base thereof
Because of bunch (gene cluster), including: OpS1 (BBA_08179), OpS2 (BBA_08180),
OpS3(BBA_08181)、OpS4(BBA_08182)、OpS5(BBA_08183)、OpS6(BBA_08184)
With OpS7 (BBA_08185) (Fig. 2).
Oosporein biological synthesis gene cluster dependency and the determination of integrity
Owing to the biosynthesis gene of microbial secondary metabolite is that linked in clusters exists on chromosome,
The present inventor knocks out experiment to each gene obtained in sequence, with checking acquisition gene cluster and ovum
The biosynthetic dependency of p0-357 and integrity thereof.
Gene knockout OpS1, OpS3, OpS4, OpS5, OpS6, or OpS7 have interrupted oosporein completely
Generation and gene overexpression OpS1, OpS3, OpS4, OpS5, or OpS7 can increase the product of oosporein
Amount, it was demonstrated that the gene cluster screened relevant to oosporein biosynthesis really;Gene knockout OpS2
Add the yield of oosporein on the contrary, illustrate that OpS2 has the effect of suppression oosporein synthesis;Thus demonstrate,prove
Real, the gene cluster obtained contains all genes required for oosporein biosynthesis.At each clpp gene
Removing or in process LAN mutant, the generation having interrupted oosporein completely having, some yield is varied from,
Have has not significant impact, and the noval chemical compound that has having occurs.
Based on above experimental result, and compare with similar compound biological synthesis gene cluster, the present inventor
Determine that the biological synthesis gene cluster of oosporein comprises 7 opening code-reading frames (Fig. 2) from OpS1 to OpS7,
Contain the region of chromosome 22 kb.In whole gene cluster, OpS1 encodes polyketide synthase/orsellinic acid synthase
(Polyletide Synthase/Orsellinic acid Synthase), OpS2 encode transport protein
(Transporter), OpS3 encoding transcription factors (Transcription Factor), OpS4 coding
Hydroxylase (Hydroxylase), OpS5 encoding laccases (Laccase), OpS6 coding for glutathion S
Transferring enzyme (Glutathione S-Transferases/GSTs), OpS7 encode Cupin albumen (Cupin
Domain containing protein) (table 1, Fig. 2).
Table 1
Wherein, " " refers to " not producing ";" NA " refers to " not doing process LAN experiment ".
The route of synthesis of oosporein precursor
Polyketide synthase (PKS) is a class multifunctional enzyme, is made up of multiple modules, with S-acetyl-coenzyme-A
(Acetyl-CoA) be starting material, each module with malonyl coenzyme A (Malonyl-CoA) as precursor,
Introduce two carbosilane units successively.PKS starting module comprises only AT-domain and ACP-domain, presses
The order arrangement of " AT-ACP ".Its extension of module is made up of three Core domains (Core-domain),
I.e. ketone ester acyl synthetic domain (KS-domain), acyl group transfer organization territory (AT-domain) and acyl group carries
Body protein domain (ATP-domain), by the order arrangement of " KS-AT-ACP ".Last of PKS
Individual module is possibly together with a thioesterase domain (Te-domain), by the order of " KS-AT-ACP-Te "
Arrangement.Except these core textures are overseas, often possibly together with some modification structure territories in PKS
(Tailoring-Domain), such as ketone ester acyl reductase domain (KR-domain), dehydrogenase structure
Territory (DH-domain), enoyl reduction enzyme domains (ER-domain) and methyl transferase domains
(MT-domain) etc..PKS can be divided into 3 classes according to structure difference, and wherein the PKS of fungus belongs to type I
Iterative type PKS.Type I iterative type PKS comprises only a module, by the recycling to this module
Synthesize different products.Gene OpS1 is predicted to be type I iterative type PKS encoding gene, and and structure
Orsellinic acid synthase gene (orsA) homology in nest aspergillosis, the domain composition of the PKS that they are coded is right
Ratio is as shown in figure 11.
The precursor orsellinic acid of oosporein is demonstrated experimentally is responsible for synthesis by OpS1 (PKS).Specifically,
Inventor carries out orsellinic acid covering feeding trial and finds beauveria bassiana Δ OpS1 mutant, orsellinic acid
Adding the ability making mutant Δ OpS1 recover synthesis oosporein, therefore explanation orsellinic acid is strictly ovum spore
The precursor of mycin synthesis, and it is responsible for synthesis by OpS1.
The biosynthesis pathway of oosporein
Inventor is found through experiments, as shown in figure 19, the biosynthesis of oosporein by OpS1, OpS4,
OpS5, OpS7 mediate.
Specifically, the biosynthesis pathway of oosporein is as follows:
(1) synthesis that polyketide synthase OpS1 is catalytic material orsellinic acid with S-acetyl-coenzyme-A;
(2) orsellinic acid is catalyzed by hydroxylase Ops4, generates " compound 2 " (three through decarboxylation hydroxylation reaction
Hydroxy-methylbenzene);
(3) " compound 2 " is unstable, can be converted into its ketone form structure " compound 3 ", and chemical combination
Thing 2 oxidation polymerization can form a small amount of " compound 4 " (5,5 '-dideoxy oosporein);
(4) " compound 2 " (trihydroxytoluene) generates tetrahydroxy through Cupin albumen OpS7 hydroxylating
Toluene, a small amount of tetrahydroxy toluene can be converted into its ketone form structure " compound 1 ";
(5) tetrahydroxy toluene is catalyzed by laccase OpS5, and oxidized and free radical dimerization generates ovum spore
Mycin.
Carrier
Term used herein " carrier " includes that the clone that insertion genes of interest can be made to enter host cell expression carries
Body and other carriers.Expression vector can include prokaryotic expression carrier and carrier for expression of eukaryon, can be plasmid, stick
Grain, phage or virus etc..Typical expression vector is with making the regulating and controlling sequence of gene expression, and in suitable position
It is equipped with the restriction endonuclease sites that can be inserted into exogenous gene.
In a particular embodiment, expression vector of the present invention contains the oosporein biosynthesis gene of the present invention,
Or the oosporein biological synthesis gene cluster containing the present invention.
Host cell
Term used herein " host cell " has the implication that those of ordinary skill in the art are generally understood that, i.e.
Comprise exogenous genes of interest and the cell expressed can be allowed to.Such as, host cell can be prokaryotic host cell
(such as, escherichia coli, bacillus subtilis, streptomycete, small single-cell bacteria), eukaryotic host cell (such as, yeast),
Plant cell etc..
In a particular embodiment, the host cell of the present invention preferably comprises the expression vector of the present invention, or dyeing
The oosporein biosynthesis gene of the external source having single copy or multicopy is integrated on body, or single copy or multicopy
Oosporein biological synthesis gene cluster.
In a preferred embodiment, the host cell of the present invention includes beauveria bassiana, Pichia sp..
Preferably, the engineering bacteria of the present invention is by beauveria bassiana (Beauveria bassiana ARSEF2860)
Genetic engineering modified and obtain.
The sudden change beauveria bassiana of structural gene inactivation in oosporein biological synthesis gene cluster
The present invention also provides for a kind of beauveria bassiana mutant, and in described mutant, the oosporein of the present invention is biological
One or more gene inactivations of synthetic gene, thus described mutant does not produce oosporein.
In a particular embodiment, one or more genes of described inactivation selected from coding such as SEQ ID NO.:9,
Gene shown in 11-15.More preferably, the described gene that is deactivated is selected from OpS1, OpS3, OpS4, OpS5, OpS6
Or OpS7.
The ball spore that in the oosporein biological synthesis gene cluster that the present invention provides, one or more structural genes are deactivated
Muscardine mutant, can as the model of gene function or control strain in checking oosporein gene cluster, and/or
Host cell for heterogenous expression oosporein.
In oosporein biological synthesis gene cluster, red ferment is finished in sudden change beauveria bassiana or the sudden change of structural gene process LAN
Female
The present invention also provides for a kind of beauveria bassiana mutant, and in described mutant, the oosporein of the present invention is biological
One or more gene overexpressions of synthetic gene, thus described mutant improves or recovers to produce oosporein.
In a particular embodiment, one or more genes of described process LAN are selected from encoding such as SEQ ID NO.:
9, gene shown in 11-15.More preferably, described be deactivated gene selected from OpS1, OpS3, OpS4, OpS5,
Ops6 or OpS7.
The ball spore of one or more structural gene process LAN in the oosporein biological synthesis gene cluster that the present invention provides
Muscardine mutant, can as the model of gene function or control strain in checking oosporein gene cluster, and/or
Host cell for heterogenous expression oosporein.
Main advantages of the present invention include:
(1) present invention is that ooecium mycin provides biosynthesis pathway, explores a kind of new biosynthesis machine
System.
(2) clone gene of nucleotide sequence provided by the present invention or at least part of nucleotide sequence can lead to
Cross suitable expression system to express to obtain corresponding enzyme or other higher biological activitys in foreign host
Or yield.These foreign host include streptomycete, beauveria bassiana, pseudomonas, escherichia coli, spore
Bacillus, yeast, plant and animal etc..
(3) present invention the most enough discloses the structure of a kind of ooecium mycin biological synthesis gene cluster, and to respectively
The function of individual gene is analyzed and researched.
(4) the invention provides a kind of new method finding reticent intermediate product, i.e. by regulation and control base
In cause bunch, the transcription factor of each gene expression carries out process LAN in mutant, thus obtains intermediate product.
Below in conjunction with specific embodiment, the present invention is expanded on further.Should be understood that these embodiments are only used for
The bright present invention rather than restriction the scope of the present invention.The experiment side of unreceipted actual conditions in the following example
Method, generally according to normal condition such as Sambrook et al., molecular cloning: laboratory manual (New York:Cold
Spring Harbor Laboratory Press, 1989) condition described in, or according to institute of manufacturer
The condition of suggestion.Unless otherwise indicated, otherwise percentage ratio and number be by weight.
Universal method:
1. the method for transformation of Agrobacterium tumefaciems AGL-1
Prepared by 1.1 Agrobacterium tumefaciems AGL-1 competence:
(1) with toothpick picking original strain AGL-1, in YEB flat board (containing 50 μ g/ml Carbenicillins)
Go up the most streak culture activation.(2) single bacterium colony on picking flat board, is seeded to 4ml YEB fluid medium and (contains
50 μ g/ml Carbenicillins) in, 28 DEG C, 200rpm, overnight incubation.(3) take the above-mentioned bacterium solution of 2ml
It is forwarded in 50ml YEB fluid medium (containing 50 μ g/ml Carbenicillins), 28 DEG C, 200rpm,
Cultivation to bacterium solution OD600 is 0.5 (the most about 8h).(4) take out bacterium solution, ice bath 30min, 4 DEG C, 8000
Rpm, 5min are centrifugal collects thalline.(5) abandon supernatant, add the 10ml resuspended thalline of 20mM CaCl2 and sink
Form sediment.(6) 4 DEG C, 8,000rpm, 5min, recentrifuge collects thalline.(7) supernatant, with 2ml 20mM
The most resuspended thalline of CaCl2, adds sterile glycerol to final concentration of 15~20%.Subpackage is managed to 1.5ml EP,
100 μ l/ pipes, are stored in-80 DEG C after liquid nitrogen flash freezer.
1.2 Plastid transformation Agrobacterium tumefaciems AGL-1 competence:
(1) take out-80 DEG C of frozen Agrobacterium competence, be placed in thawed on ice about 10min.(2) to competence
In add 0.5~the plasmid of 1 μ g mesh, stand 30min after mixing on ice.Process as follows the most successively: liquid nitrogen 5min,
37 DEG C of water-bath 5min, are immediately placed on 2min on ice after process.(4) add 1ml nonreactive YEB liquid culture
Base, 28 DEG C, 150rpm, recovery 3h.(5) 8,000rpm, 2min are centrifugal collects thalline.(6) abandon
Clearly, (blue or green containing 50 μ g/ml carboxylic benzyls to be spread evenly across YEB flat board after the 100 μ resuspended thalline of l nonreactive YEB
Mycin and 50 μ g/ml kanamycin), it is inverted for 28 DEG C and cultivates 2 days.(7) PCR verifies transformant, picking
Positive transformant is with 3ml YEB liquid (containing 50 μ g/ml Carbenicillins and 50 μ g/ml kanamycin)
Overnight shake bacterium, 28 DEG C, 220rpm.(8) bacterium solution taking part and is stored in-80 DEG C, final glycerol concentration is 15%.
The genetic transformation of the most Agrobacterium tumefaciens mediated beauveria bassiana:
(1) the preparation of conidia of beauveria bassiana spore suspension: choose and cultivate on solid potato culture medium PDA plate
The beauveria bassiana of two weeks, scrapes appropriate mycelia to 1ml aseptic 0.05%Tween-20 aqueous solution, vortex
Vibration separates mycelia and conidium;Filter remove mycelia with glass silk flosssilk wadding or three layers of lens paper, collect filtrate;
12,000rpm, 1min, centrifugal bacterium solution collects spore;Abandon supernatant, with the resuspended spore of 1ml sterilized water,
Remove remaining nutrition;12,000rpm, 1min, recentrifuge collects spore;Repeatable step 4~5 one
Secondary, thoroughly to remove spore surface remnants nutrition;Abandon supernatant, with the resuspended spore of appropriate amounts of sterilized water, hemocytometer
After number device statistics spore number, spore suspension concentration is adjusted to 5 × 105Conidia/ml, uses as working solution
Operate in subsequent experimental.(2) muscardine converts: the frozen bacterium of AGL-1 of the successful conversion respective carrier of transferring is extremely
3ml liquid YEB (containing 50 μ g/ml Carbenicillins and 50 μ g/ml kanamycin), 28 DEG C, 220
Rpm, overnight incubation;8,000rpm, 2min, centrifugal collection thalline;Abandon supernatant, with appropriate IM liquid
Body weight hangs thalline, adjusts to OD650It is 0.15;28 DEG C, 150rpm, inducing culture to OD650It is 0.5~0.8,
Typically need 6h;Take each 100 μ l of muscardine spore suspension of the Agrobacterium bacterium solution induced and fresh preparation, in
1.5ml EP pipe is mixed evenly;Taking above-mentioned mixed liquor 100 μ l and coat IM flat board, 28 DEG C co-culture
48h;M-100 solid medium temperature after subject to sterilization is down to 60 DEG C, add corresponding antibiotic (cephalothin,
Phosphine oxamate/benomyl);Every piece co-cultures IM flat board and covers with 15ml above-mentioned M-100 culture medium, 25 DEG C
Cultivate 3-5 days and occur to single resistant clones;With toothpick, above-mentioned resistant clones picking is resisted to new M-100
On property culture medium flat plate, carry out programmed screening;With SDB fluid medium to resisting on postsearch screening flat board
Property bacterium colony shake bacterium and cultivate, and carry out labelling in the relevant position at the M-100 flat board back side;Sucking filtration SDB cultivates bacterium
Silk, extracts genome, carries out PCR checking.
The most agriculture bacillus mediated fungal transformation solution and culture medium
The basic salts solution of 2.5 × inducing culture
KH2PO4 | 3.625g |
K2HPO4·3H2O | 6.72g |
MgSO4·7H2O | 1.250g |
NaCl | 0.375g |
CaCl2 | 0.125g |
FeSO4·7H2O | 0.0062g |
(NH4)2SO4 | 1.250g |
Distilled water | Finally it is settled to 1 liter |
M-100 trace element solution
H3BO3 | 30mg |
MnCl2·4H2O | 70mg |
ZnCl2 | 200mg |
Na2MoO4·2H2O | 20mg |
FeCl3·6H2O | 50mg |
CuSO4·5H2O | 200mg |
Distilled water | Finally it is settled to 500 milliliters |
M-100 saline solution
KH2PO4 | 16g |
Na2SO4·10H2O | 9.064g |
KCl | 8g |
MgSO4·7H2O | 2g |
CaCl2 | 1g |
M-100 trace element solution | 8ml |
Distilled water | Finally it is settled to 1 liter |
Inducing culture (liquid)
Add after being cooled to 50 DEG C after sterilizing:
Inducing culture (solid)
Add after being cooled to 50 DEG C after sterilizing:
M-100(For 1L)
M-100 saline solution | 62.5ml |
Glucose | 10g |
KNO3 | 3g |
Distilled water | Finally it is settled to 1 liter |
Agar powder | 15g |
MES and AS mother liquor:
Store liquid concentration | PH (adjusts with 5M KOH) | |
2-(morpholine) ethyl sulfonic acid MES | 1M | 5.3 |
Acetosyringone AS | 10mM | 8 |
4. oosporein isolation and purification method:
The extraction of 4.1 oosporeins:
Separate muscardine mycelia and culture medium with suction method, 50 DEG C of vacuum rotations of fermentation liquor of isolated are steamed
Concentrate 1/4th for original volume.In the fermentation liquid concentrated, add trifluoroacetic acid and concussion shakes up to fermentation
Liquid is become orange (pH ≈ 2) from aubergine.With the long-pending ethyl acetate extractive fermentation liquid of triploid, separation has
Machine phase and aqueous phase.Ethyl acetate is evaporated through vacuum rotation steaming, is finally dissolved in proper amount of methanol.
The separation of 4.2 oosporeins:
First macroporous resin D101 is suspended in industrial alcohol, and fills in chromatographic column.With pH ≈'s 2
Filler macroporous resin in water (adjusting pH with trifluoroacetic acid) balance chromatographic column is to the eluent pH ≈ 2 flowed out (i.e.
The aobvious acidity of macroporous resin).Gained oosporein crude extract is uniformly dripped in chromatographic column top, makes sample fill
Divide and be adsorbed on macroporous resin.With water (pH ≈ 2) as flowing 3 column volumes of phase eluting, then use hydrogen
Potassium oxide aqueous solution (pH ≈ 12) elution samples.Collect the purple solution eluted, adjust with trifluoroacetic acid
To pH ≈ 2 (solution becomes orange), with after through 1/10th of vacuum concentrated by rotary evaporation to original volume.Use second
Acetoacetic ester extracts solution again, and concentration is evaporated, and dissolves with a little methanol, is loaded in EP pipe.By EP
After pipe is placed in-20 DEG C of precipitates overnight, 12000rpm is centrifuged 1min, collects precipitation.Precipitation is precipitation
Oosporein crystal.
The Specification Curve of Increasing of oosporein under 5.UV 287nm.
With isolated and purified oosporein be each configured to concentration be 10mg/ml, 8mg/ml, 6mg/ml,
The dimethyl of 4mg/ml, 2mg/ml, 1mg/ml, 0.8mg/ml, 0.6mg/ml and 0.4mg/ml
Sulfoxide (DMSO) solution.HPLC detection, applied sample amount 3 μ l under the conditions of UV 287nm.Calculate
The integrated peak areas of oosporein under variable concentrations, is depicted as oosporein standard curve.Lienarized equation is:
Y=2E-07x-0.4486 (y is the quality of oosporein, and x is oosporein peak area).
6. the preparation of beauveria bassiana RNA
The extracting of 6.1 muscardine RNA:
(1) liquid nitrogen grinding freezing muscardine mycelia becomes powder, takes 100mg in EP pipe;(2) immediately
Add 1ml Trizol, with liquid-transfering gun piping and druming mixing, count 1/5 volume (200 μ l) chloroform, mixing,
2-3min is placed on ice;(3) in 12000rpm, 4 DEG C of centrifugal 5min, draw supernatant 400 μ l in separately
In one EP pipe, add 1/2 volume (200 μ l) chloroform: isoamyl alcohol (24:1), mixing;(4) 12000rpm,
4 DEG C of centrifugal 5min, proceed to supernatant (repeatedly Deproteinization) in another EP pipe, add 1/2 volume
(200 μ l) isopropanol, mixing, stand 10min on ice;(5) 12000rpm, 4 DEG C of centrifugal 15min,
Abandon supernatant, add 800 μ l 75% ethanol and wash 2 times;(6) 12000rpm, 4 DEG C of centrifugal 5min, abandon
Clearly, room temperature is dried;(7) with 50 μ l DEPC water dissolution RNA precipitate;(8) RNA concentration is measured.
6.2 removal DNA impurity:
Configure the reaction system of 50 μ l, degradation of dna:
10×buffer | 5μl |
Total serum IgE | 45μl |
RRI | 1μl |
DNase I | 1μl |
1h is reacted in 37 DEG C.
6.3 recovery purifying RNAs:
(1) 50 μ l reaction system adds 50 μ lDEPC water, adds 100 μ l chloroforms: isoamyl
Alcohol (24:1), mixing;(2) 12000rpm, 4 DEG C of centrifugal 5min, move into another EP pipe by supernatant
In, add 100 μ l chloroforms: isoamyl alcohol (24:1) mixes;(3) 12000rpm, 4 DEG C of centrifugal 5min,
Supernatant is moved in another EP pipe, adds 10 μ l 3M sodium acetates and 250 μ l dehydrated alcohol (ice bath),
Mixing, places 20min in-80 DEG C;(4) 12000rpm, 4 DEG C of centrifugal 10min, abandon supernatant, with 800 μ l
75% ethanol washes 2 times;(5)12000rpm.4 DEG C of centrifugal 5min, collect precipitation, dry, with 30 μ l DEPC
Water dissolution;(6) RNA concentration is surveyed.
7. the preparation (TOYOBO RNA reversal agents box) of beauveria bassiana cDNA
7.1RNA degeneration:
Configure 12 μ l reaction systems
After 65 DEG C of reaction 5min, it is immediately placed on ice.
7.2RNA inverts:
Configuration reversion reaction system 20 μ l
The RNA of deformation | 12μl |
5×RT buffer | 4μl |
dNTP Mixture | 2μl |
RNase Inhibitor | 1μl |
Rever Tra Ace | 1μl |
Response procedures
30℃ | 10min |
42℃ | 20min |
85℃ | 5min |
4℃ | 5min |
8. the method for transformation of Pichia pastoris GS115
8.1 Pichia sp. electricity turn competent preparation:
(1) from YPD flat board, choose the mono-bacterium colony of GS115, be inoculated in 5ml routine YPD culture medium,
30 DEG C of shaking table overnight incubation;(2) take seed culture fluid 0.02-0.1ml, be inoculated in 2 bottles of 50ml respectively
In YPD culture medium (being loaded on 250ml triangular flask), incubated overnight to OD600=1.3-1.5;(3) by two
Bottle bacterium solution is sub-packed in 2 50ml centrifuge tubes, in 1500g, 4 DEG C of centrifugal 5min, use 50ml respectively
The outstanding thalline of sterilized water punching of ice bath;(4) 1500g, 4 DEG C of centrifugal 5min, respectively with 25ml ice bath
The resuspended thalline of sterilized water;(5) recentrifuge (method is ibid), respectively with the ice bath 1M Pyrusussuriensis of 2ml
The resuspended thalline of alcohol;(6) centrifugal (ibid), respectively with the resuspended thalline of 1M sorbitol of 0.1ml ice bath,
And be sub-packed in the EP pipe of pre-cooling, often pipe 80 μ l, it is placed in the most standby.
8.2 Pichia sp. electricity shifting methods:
(1) take linearizing plasmid 5-10 μ g to be added on GS115 electricity and turn in competence bacterium solution, mixing;(2)
By mixing competence bacterium solution move into pre-cooling electric revolving cup (2mm) in, place 5min on ice;(3)
Electricity turns (2kv);(4) in electricity revolving cup, the 1M sorbitol 1ml of ice bath is added rapidly, by mixed liquor
Proceed in 1.5ml EP pipe;(5) bacterium solution is placed in 30 DEG C of stationary incubation 1-2h;(6) bacterium solution is mixed
Even, take 200 μ l bacterium solution and be applied on the YPDS flat board of bleomycin/Geneticin, cultivate 2-3 days for 30 DEG C.
The screening of 8.3 Pichia sp. mutants:
(1) going to screen the mutant colonies on flat board with rifle choicest, the YPD being inoculated in 3ml respectively cultivates
In base (containing bleomycin/Geneticin), cultivate 24h with 30 DEG C of shaking tables;(2) bacterium solution 1ml is taken respectively
In corresponding EP pipe;(3) 12000rpm is centrifuged 1min, abandons supernatant;(4) respectively with 200 μ l
Lysate thalline is resuspended, be separately added into the 0.5mm porcelain bead of 100mg;(5) shake on agitator
Swing 8 times, each 30s;(6) 12000rpm is centrifuged 1min, is moved into by supernatant in another EP pipe;
(7) PCR verifies mutant.
The fermentation of 8.4 Pichia sp. and abduction delivering:
(1) take the Pichia sp. bacterium solution 100 μ l in conventional YPD culture medium, be inoculated in 50ml MGY training
Supporting base (being loaded in 250ml triangular flask), 30 DEG C, 24h cultivated by 220rpm shaking table;(2)1500g
Centrifugal 5min, abandons supernatant, with the 1ml resuspended thalline of routine MMH culture medium, transfers in 100ml MMH
Culture medium (is loaded on 500ml triangular flask), is adjusted to OD600=1;(3) in MMH culture medium, add 0.5%
Methanol (500 μ l), inducible gene expression, 30 DEG C, 220rpm shaking table cultivate 48h.
9. Pichia sp. converts and expresses used medium
YPD+Agar culture medium (For 100ml) (Geneticin 0.5mg/ml or bleomycin 0.1
mg/ml)
Yeast extract | 1g |
Peptone | 2g |
Glucose | 2g |
Agar powder | 1.5g |
Distilled water | 100ml |
YPD culture medium (For 100ml) (Geneticin 0.5mg/ml or bleomycin 0.1mg/ml)
Yeast extract | 1g |
Peptone | 2g |
Glucose | 2g |
Distilled water | 100ml |
MGY culture medium (For 100ml)
YNB | 1.34g |
Glycerol | 1ml |
Vitamin B | 0.04mg |
Histidine | 4mg |
Distilled water | Add to 100ml |
MMH culture medium (For 500ml)
1.34%YNB | 6.7g |
Histidine | 20mg |
Vitamin B | 0.2mg |
Methanol | 2.5ml |
Distilled water | Add to 500ml |
Lysate
The qualification of embodiment 1 oosporein synthetic gene bunch
Beauveria bassiana ARSEF 2860 is checked order, it is thus achieved that the genomic data of order-checking, to these data
Compare genome analysis, have found OpS1 and the gene cluster at place thereof in beauveria bassiana, wherein wrap
Include: OpS1 (BBA_08179), OpS2 (BBA_08180), OpS3 (BBA_08181), OpS4 (BBA_08182),
OpS5 (BBA_08183), OpS6 (BBA_08184) and OpS7 (BBA_08185) (Fig. 2).
Bioinformatic analysis shows, these genes may be separately encoded following albumen, including: OpS1 encodes
Polyketide synthase/orsellinic acid synthase, OpS2 coding transport protein, OpS3 encoding transcription factors, OpS4 coding
Hydroxylase, OpS5 encoding laccases, OpS6 coding for glutathion S transferring enzyme, OpS7 encode Cupin albumen
(table 1).
Embodiment 2 oosporein synthesis related gene and the qualification of function thereof
Respectively to OpS1 (BBA_08179), OpS2 (BBA_08180), OpS3 (BBA_08181),
OpS4 (BBA_08182), OpS5 (BBA_08183), OpS6 (BBA_08184) and OpS7 (BBA_08185)
Carry out knocking out and process LAN, and by high performance liquid chromatography (HPLC), the fermentation liquid knocking out mutant has been carried out
Detection, the impact that oosporein is synthesized by the disappearance of observation specific gene or process LAN.
The impact of each gene pairs oosporein synthesis in 2.1OpS gene cluster
The pDHt-ks of binary vector pCAMBIA1300 conventional in plant genetic, as skeleton, divides wherein
Not Yin Ru cremart resistant gene Bar and benomyl resistance gene Ben, construct for fungal transformation is double
Unit carrier pDHt-Bar and pDHt-Ben;Based on carrier pDHt-Bar, construct respectively for knocking out
The knockout carrier of gene OpS1, OpS2, OpS3, OpS4, OpS5, OpS6 and OpS7.
Use primer OpS1UF/OpS1UR and OpS1DF/OpS1DR (concrete primer sequence is shown in Table 2), point
Other PCR amplifies the upstream and downstream homology arm of knockout carrier, and is connected to upstream and downstream homology arm fragment carry
The upstream and downstream site (Fig. 3) of body pDHt-Bar.Plastid transformation crown gall agriculture bar is knocked out with the OpS1 built
Bacterium AGL-1 obtains the Agrobacterium containing knockout carrier, is used for converting beauveria bassiana ARSEF 2860.Pass through
The screening of cremart resistant panel obtains the OpS1 of beauveria bassiana and knocks out mutant (Δ OpS1)
Knock out the most successively, it is thus achieved that knock out mutant Δ OpS1, Δ OpS2, Δ OpS3, Δ OpS4,
Δ OpS5, Δ OpS6 and Δ OpS7, collect each mutant and wild type respectively with the Tween solution of 0.05%
The spore of bacterial strain WT, making concentration is 108The spore suspension of individual spore/ml, takes 40 μ l spore suspensions and divides
Not being inoculated in the triangular flask equipped with 20ml SDB culture medium, in 25 DEG C, 200rpm shaking table is cultivated 3 days,
As seed culture medium.
Take 1ml seed culture medium to be inoculated in respectively in the triangular flask equipped with 50ml SDB culture medium, juxtaposition
(light application time is 12h/ days), quiescent culture 5 days in 25 DEG C of illumination boxs.Finally, bacterium is filtered off
Filament, collects fermentation liquid.
Result shows, as shown in Figure 4, the fermentation liquid of wild-type strain WT takes on a red color, except Δ OpS2 ferments
Liquid redness deepen outside, other genes knock out mutant fermentation liquid all without color.
Being extracted with ethyl acetate fermentation liquid, gained crude extract is after vacuum concentrated by rotary evaporation, by methanol-eluted fractions and use
High performance liquid chromatography (HPLC) detects.HPLC detection use CNW company C18 post (, 4.6mm × 250
Mm, 5 μm).Elution requirement is: column temperature 40 DEG C, water (containing 0.1% trifluoroacetic acid): acetonitrile=87:13,
Eluting 35min.Ultraviolet detection wavelength is UV 287nm.
Testing result as it is shown in figure 5, in figure the peak of oosporein be marked as redness.Result shows, gene
The disappearance of OpS1, OpS3, OpS4, OpS5, OpS6 and OpS7 causes oosporein to synthesize, and base
Disappearance because of OpS2 adds the yield of oosporein on the contrary.
Table 2
The regulation and control that oosporein is synthesized by 2.2 transcription factor OpS3
Qualitative experiment:
Based on carrier pDHt-Ben, construct the over-express vector of gene OpS3, use primer
GpdA-F/gpdA-R (table 2) amplifies beauveria bassiana glyceraldehyde 3-phosphate dehydro-genase gpdA through PCR
(BBA_05480) promoter is connected at the restriction enzyme site SpeI in carrier pDHt-Ben downstream, it is thus achieved that
Carrier pDHt-Ben-gpdA.Then, obtain gene OpS3 with primer OpS3-F/OpS3-R (table 2) amplification,
And be connected at the restriction enzyme site XbaI of carrier pDHt-Ben-gpdA downstream.With checking primer
GpdA-YF/OpS3-YR (table 2) verifies closure, gained over-express vector pDHt-ben-gpdA-OpS3
Structure is as shown in Figure 6.
The carrier built is passed through the mediated transformation beauveria bassiana of Agrobacterium tumefaciems AGL-1, through containing benzene
The resistant panel screening of bacterium spirit obtains the process LAN mutant WT::OpS3 of beauveria bassiana OpS3 gene.
Collect beauveria bassiana wild-type strain WT, Δ OpS3 mutant and process LAN mutant respectively
The spore of WT::OpS3, making concentration is 108The spore suspension of individual spore/ml, ferment each mutant and open country
Raw type bacterial strain, filters and separates mycelium and fermentation liquid, as it is shown in fig. 7, the fermentation liquid of wild-type strain WT
Taking on a red color, the fermentation liquid of Δ OpS3 bacterial strain is without color, and the fermentation liquid redness of WT::OpS3 is deepened.
The fermentation liquor HPLC detection that will collect, testing result shows, the process LAN of OpS3 can significantly carry
The yield of high oosporein, the disappearance of OpS3 then causes muscardine cannot synthesize oosporein (Fig. 8, ovum
The peak of p0-357 is marked as redness).
Quantitative experiment:
Drawing oosporein with isolated and purified oosporein standard specimen is UV 287 at HPLC ultraviolet detection wavelength
Standard curve under the conditions of nm.With the peak area ratio of oosporein to standard curve, obtain wild-type strain
The oosporein yield of WT and each mutant, as shown in Figure 9.
Result shows, the process LAN of transcription factor gene OpS3 significantly improves the yield of oosporein, from
About 150 μ g/ml are brought up to less than 50 μ g/ml.
Study on mechanism:
Extract wild type WT, Δ OpS3 mutant and the mycelium RNA of process LAN mutant WT::OpS3 respectively
And reverse transcription obtains cDNA.By Semiquatitative RT-PCR assay detection other genes of OpS gene cluster at wild-type bacteria
Expression (Figure 10, tubulin gene is internal standard) in strain WT and OpS3 mutant.
Result shows, compared to wild-type strain, the disappearance of gene OpS3 causes other oosporeins to synthesize
The silence of related gene expression, the process LAN of OpS3 then drastically increases the expression of these genes.
The Function Identification of 2.3 polyketide synthase OpS1
Beauveria bassiana Δ OpS1 mutant is carried out orsellinic acid (Formulas I) covering feeding trial.By white for ball spore
The seed culture medium of stiff bacterium wild-type strain WT and Δ OpS1 mutant is inoculated in respectively equipped with 50ml SDB
In the triangular flask of culture medium.Wild type WT inoculates 3 bottles, and Δ OpS1 mutant inoculates 6 bottles, and wherein 3
Bottle adds orsellinic acid (OrA) ethanol solution of 300 μ l (100mg/ml), and other 3 bottles add 300 μ l
Ethanol as comparison, ferment 5 days, collect fermentation liquid (Figure 12).
Result shows, the fermentation liquid of wild type WT takes on a red color, and is not added with the Δ OpS1 mutant of orsellinic acid
Fermentation liquid is colourless, and the Δ OpS1 mutant fermentation liquid that with the addition of orsellinic acid also takes on a red color.
Meanwhile, fermentation liquor HPLC of different disposal being detected, ultraviolet detection wavelength is UV 254nm.
As shown in figure 13, in figure, the peak of orsellinic acid is marked as yellow to result, and the peak of oosporein is marked as
Red.As seen from the figure, the interpolation of orsellinic acid makes to recover in mutant Δ OpS1 the ability of synthesis oosporein,
This explanation orsellinic acid is strictly the precursor of oosporein synthesis, and is responsible for synthesis by OpS1.
Pichia sp. heterogenous expression:
By gene OpS1 (BBA_08179) and phosphopantetheine acyltransferase (PPTase) gene
BBA_06793 expands out (table 2) from beauveria bassiana cDNA, respectively with carrier pPICZB and
PPIC3.5K connects, and obtains heterologous expression vector pPICZB-OpS1 and pPIC3.5K-06793, and successively
Convert GS115, after bleomycin and Geneticin screen, obtain different in Pichia sp. of gene OpS1
Mutant GS115::OpS1 is expressed in source.
By wild-type strain GS115 and OpS1 heterogenous expression mutant GS115::OpS1 in MMH culture medium
In in 30 DEG C, 220rpm shaking table cultivate 48h.4000rpm is centrifugal collects fermentation liquid, by wild type and
The fermentation liquid of heterogenous expression mutant and orsellinic acid standard specimen (OrA) detect through HPLC respectively, ultraviolet detection ripple
A length of UV 210nm.
As shown in figure 14, orsellinic acid is marked as yellow to result, Pichia sp. wild-type strain GS115's
Fermentation liquid does not accumulate peak, and finds in the fermentation liquid of OpS1 heterogenous expression bacterial strain GS115::OpS1
The accumulation peak of orsellinic acid, molecular weight is MW=168.It is demonstrated experimentally that OpS1 (PKS) is responsible for orsellinic acid
Synthesis.
The Function Identification of 2.4 other related genes
As it is shown in figure 5, the disappearance of OpS4, OpS5, OpS6 and OpS7 all causes oosporein not synthesize,
But in its fermentation liquid, do not find the accumulation of intermediate product.Therefore, respectively knock out in mutant to find
The accumulation peak of oosporein synthetic intermediate, transcription factor OpS3 respectively is being knocked out in mutant by inventor
Row process LAN.
Over-express vector pDHt-Ben-gpdA-OpS3 is converted respectively knock out mutant Δ OpS4, Δ OpS5,
Δ OpS6 and Δ OpS7, obtain transcription factor process LAN mutant Δ OpS4::OpS3, Δ OpS5::OpS3,
Δ OpS6::OpS3 and Δ OpS7::OpS3.Fermentation wild-type strain and mutant (Δ OpS1, Δ OpS2,
Δ OpS3, Δ OpS4::OpS3, Δ OpS5::OpS3, Δ OpS6::OpS3 and Δ OpS7::OpS3) and
Collect fermentation liquid.
Result shows, in addition to wild type WT and Δ OpS2 mutant fermentation liquid take on a red color, the most colourless
OpS5, OpS6 and OpS7 knock out mutant, after process LAN transcription factor, present redness and orange respectively
Color (Figure 15).
Subsequently, being detected by above-mentioned fermentation liquid HPLC, ultraviolet detection wavelength is UV 254nm.
Result shows (Figure 16):
(1) in the fermentation liquid of mutant Δ OpS4::OpS3, there is the accumulation peak (molecular weight of an orsellinic acid
For MW=168), it is marked as yellow.
(2) in the fermentation liquid of mutant Δ OpS5::OpS3, there is the peak of accumulation, be labeled as blueness, chemical combination
Thing molecular weight is MW=154, named " compound 1 ".
(3) having a molecular weight in the fermentation liquid of mutant Δ OpS7::OpS3 is the accumulation of MW=140
Peak, is marked as green, named " compound 2 ", is MW=138 in addition with an accumulation peak molecular weight,
It is marked as orange, named " compound 3 ".
(4) in mutant Δ OpS5::OpS3, Δ OpS6::OpS3 and Δ OpS7::OpS3, all have one
Individual accumulation peak, molecular weight is MW=274, is labeled as a piece redness, named " compound 4 ";Mutant
The fermentation liquid of Δ OpS6::OpS3 is found that the peak (molecular weight is MW=306) of oosporein, labeled
For redness.
Thus inferring, hydroxylase OpS4, laccase OpS5 and Cupin albumen OpS7 participate in catalysis with orsellinic acid
For the synthesis of the oosporein of precursor, and hydroxylase OpS4 is directly catalyzed the reaction with orsellinic acid as substrate.
And the most directly participate in the synthesis of oosporein as the OpS6 of S-glutathione transferase, and it is probably
To removing the free radical produced in oosporein building-up process, thus cell is protected to avoid the work of free radical injury
With.Hydroxylase OpS4 is the highest with the amino acid sequence homology of salicylate hydroxylase, and salicylate hydroxylase
Catalysis bigcatkin willow acid decarboxylation hydroxylating, generates catechol.Therefore inventor speculates that hydroxylase OpS4 is also catalyzed class
As react, orsellinic acid is converted into trihydroxytoluene.
2.4.1OpS4 the Function Identification of gene
For the function studying hydroxylase OpS4 further and the reaction being catalyzed thereof, inventor is by gene OpS4
Expand out from the cDNA of beauveria bassiana, and be connected on carrier pPICZB, construct gene OpS4
Heterologous expression vector pPICZB-OpS4, and convert Pichia pastoris GS115, obtain through bleomycin screening
The heterogenous expression mutant GS115::OpS4 of gene OpS4.
Respectively with MMH culture medium fermentation wild-type strain GS115 and mutant GS115::OpS4, and respectively
Each orsellinic acid adding 300 μ l (100mg/ml) in the fermentation liquid of wild type and mutant, in 30 DEG C,
24h cultivated by 220rpm shaking table.4000rpm is centrifugal collects fermentation liquid, detects with HPLC, ultraviolet detection
Wavelength is UV 254nm, and as shown in figure 17, wherein the peak of orsellinic acid is marked as yellow to result.
Result shows, as shown in figure 17, compared to the fermentation liquid of wild-type strain, OpS4 heterogenous expression is dashed forward
Orsellinic acid in the fermentation liquid of variant GS115::OpS4 is consumed and is converted into " compound 2 " in a large number, point
Son amount is MW=140, is marked as green." compound 2 " is unstable, can convert generation " compound 3 "
(MW=138) and " compound 4 " (MW=274), it is respectively labeled as orange and piece redness.
Separating " compound 4 ", identify through nuclear magnetic resonance, NMR, its structure is as shown in formula IV.
NMR(CD3OD, 400MHz):
Atom | δ |
H5/H5’ | 4.899 |
H7/H7’ | 1.875 |
C1/C1’ | 140.479 |
C2/C2’ | 157.615 |
C3/C3’ | 186.266 |
C4/C4’ | 138.260 |
C5/C5’ | 107.432 |
C6/C6’ | 182.957 |
C7/C7’ | 11.854 |
The structure of compound 4 is similar to oosporein, compared with oosporein, only lacks two hydroxyls, by
Two trihydroxytoluenes are polymerized, named " 5,5 '-dideoxy oosporein ".Due to " 5,5 '-
Dideoxy oosporein " it is " compound 2 " product of being oxidized to form, and the molecule of " compound 2 "
Amount is MW=140, therefore conclude that " compound 2 " is trihydroxytoluene, and " compound 3 " (MW=138)
For ketone form structure, structure is respectively as shown in Formula II, formula III.Therefore conclude that hydroxylase OpS4 is catalyzed glycosides color
The decarboxylation hydroxylation reaction of acid, forms a trihydroxytoluene.
2.4.2OpS7, the Function Identification of OpS5 gene
As shown in figure 16, the fermentation liquid of mutant Δ OpS7::OpS3 has the accumulation of " compound 2 ",
I.e. " compound 2 " is the substrate of OpS7." changing in isolated and purified mutant Δ OpS5::OpS3 fermentation liquid
Compound 1 " (molecular weight is MW=154), it is accredited as a quinones, structure such as formula through nuclear magnetic resonance, NMR
Shown in VI.
Inventor infers that OpS7 is a monooxygenase, the hydroxylating of catalysis " compound 2 " methyl ortho position carbon,
Generate a tetrahydroxy toluene (Formula V).When it cannot be utilized, just it is converted into more by enol-type structure
Stable ketone form structure, i.e. " compound 1 ".Studying discovery, laccase OpS5 can be by Polyphenols simultaneously
Compound is oxidized to quinones, and through radical reaction, between two free radicals, polymerization forms carbon carbon list
Key, and laccase OpS5 knocks out in mutant the accumulation having " compound 1 ", therefore inventor infers laccase
Enol-type structure " tetrahydroxy toluene " (Formula V) oxidation polymerization of OpS5 catalysis " compound 1 " forms ovum
Born of the same parents' rhzomorph (Formula VII).
NMR(CD3OD,400MHz):
Atom | δ |
H3 | 4.975 |
H7 | 1.877 |
Confirmatory experiment:
" compound 1 " of inventor's isolated feeds mutant Δ OpS7::OpS3, examines with HPLC
Surveying its fermentation liquid, result is as shown in figure 18.
From figure it will be seen that in mutant Δ OpS7::OpS3, add " compound 1 " make ovum
The synthesis of p0-357 is recovered, and therefore " compound 1 " is produced by OpS7 catalysis.
Block the synthesis of oosporein in conjunction with knocking out of Figure 16, OpS5, and result in " compound 1 "
Accumulation, therefore laccase OpS5 is that substrate synthesizes oosporein with " compound 1 ".
The route of synthesis of embodiment 3 oosporein
Inventor infers the route of synthesis of oosporein as shown in figure 19.Specific as follows:
(1) synthesis that polyketide synthase OpS1 is catalytic material orsellinic acid with S-acetyl-coenzyme-A;
(2) orsellinic acid is catalyzed by hydroxylase Ops4, generates " compound 2 " (three through decarboxylation hydroxylation reaction
Hydroxy-methylbenzene);
(3) " compound 2 " is unstable, can be converted into its ketone form structure " compound 3 ", and chemical combination
Thing 2 oxidation polymerization can form a small amount of " compound 4 " (5,5 '-dideoxy oosporein);
(4) " compound 2 " (trihydroxytoluene) generates tetrahydroxy through Cupin albumen OpS7 hydroxylating
Toluene, a small amount of tetrahydroxy toluene can be converted into its ketone form structure " compound 1 ";
(5) tetrahydroxy toluene is catalyzed by laccase OpS5, and oxidized and free radical dimerization generates ovum spore
Mycin.
Embodiment 4 oosporein has parasite killing and fungistatic effect
4.1 insecticidal test
Inventor carries out muscardine insecticidal test with greater wax moth for experimental subject.
Take beauveria bassiana wild type WT, the mutant Δ OpS1 that oosporein cannot be synthesized and ovum spore mould
(concentration is 10 to the spore suspension of element superior strain WT::OpS36Individual spore/ml), inject greater wax moth respectively
Larva, every larva injects the spore suspension of 10 μ l, every kind of bacterium 50 larvas of injection;Separately set one group of sky
White comparison, the Tween solution of injection 0.05%.By the greater wax moth larva after injection by injected spore not
With supporting in different vessels respectively, it is placed in 25 DEG C of raisings.Remember a number every 12h, observe greater wax moth
Death condition.Experimental result is as shown in figure 20.
Result shows, the parasite killing poison of beauveria bassiana wild type WT and oosporein superior strain WT::OpS3
Power is significantly stronger than the mutant Δ OpS1 that cannot synthesize oosporein, and the oosporein parasite killing muscardine is described
During play an important role.
4.2 suppression Insect immunity system experimentations
Inventor 24h, 36h and 48h after injection spore respectively takes the blood of infected greater wax moth
Lymph carries out microscopy, and result is as shown in figure 21.
From the figure, it can be seen that after injection beauveria bassiana spore 24h, wild type WT and oosporein high yield
The spore of bacterial strain WT::OpS3 has been broken through the parcel of greater wax moth hemocyte and has been started to sprout, and mutant Δ OpS1
Spore then cannot break through the parcel of hemocyte;36h after injection, when WT and WT::OpS3 spore
Start amount reproduction, and when forming hyphal body, the Δ OpS1 spore of only a few the most just starts to break through parcel and sprouts
Send out.As can be seen here, oosporein plays an important role at suppression Insect immunity system aspects.
Meanwhile, we have also observed that the corpse of the greater wax moth infected by WT and WT::OpS3 takes on a red color,
And the greater wax moth corpse infected by Δ OpS1 does not takes on a red color, and in polypide, mycelial growth is slow, such as Figure 22 institute
Show.
To sum up showing, oosporein is as the main external secretion secondary metabolite of beauveria bassiana, not only shadow
Ring the parasite killing process of beauveria bassiana, for the subsequent growth of muscardine and infect most important again.
4.3 bacteriostatic experiment
Compared with WT and WT::OpS3, the greater wax moth larva that mutant Δ OpS1 infects is easier to infect carefully
Bacterium, makes worm corpse rot smelly.Therefore, inventor infers that oosporein also has bacteriostasis, helps muscardine
The competition of other saprophytic microbes of antagonism.To this end, inventor that oosporein has been carried out gram positive bacteria is withered
The bacteriostatic experiment of grass bacillus cereus.
Experimental technique:
The oosporein aqueous solution of preparation variable concentrations, the thick filter paper of infiltration is also affixed on and long has bacillus subtilis
Culture medium flat plate on, culture medium is placed in 37 DEG C cultivate 12h.
Experimental result is as shown in figure 23:
At the filter paper that oosporein concentration is 1mg/ml and 0.8mg/ml formed around the most antibacterial
Circle, shows that oosporein has good bacteriostasis really.
The all documents mentioned in the present invention are incorporated as reference the most in this application, just as each document
It is individually recited as with reference to like that.In addition, it is to be understood that after the above-mentioned teachings having read the present invention,
The present invention can be made various changes or modifications by those skilled in the art, and these equivalent form of values fall within this Shen equally
Please appended claims limited range.
Claims (10)
1. the biological synthesis gene cluster of an oosporein, it is characterised in that described gene cluster includes encoding ovum spore
7 oosporein synthesis related gene: OpS1 involved by mycin biosynthesis, OpS2, OpS3, OpS4,
OpS5、OpS6、OpS7;
Wherein, OpS1 is positioned at gene cluster nucleotide sequence 24759-32012 position, encodes polyketide synthase/orsellinic acid
Synthase, a length of 2211 aminoacid;
OpS2 is positioned at gene cluster nucleotide sequence 32992-34102 position, encodes transport protein, and a length of 350
Individual aminoacid;
OpS3 is positioned at gene cluster nucleotide sequence 36584-38809 position, encoding transcription factors, and a length of 741
Individual aminoacid;
OpS4 is positioned at gene cluster nucleotide sequence 39149-40901 position, encoding hydroxylase, a length of 427 ammonia
Base acid;
OpS5 is positioned at gene cluster nucleotide sequence 41885-44041 position, encoding laccases, a length of 590 amino
Acid;
OpS6 is positioned at gene cluster nucleotide sequence 44430-45147 position, coding for glutathion S transferring enzyme, length
It is 218 aminoacid;
OpS7 is positioned at gene cluster nucleotide sequence 45713-46768 position, encodes Cupin albumen, and a length of 305
Individual aminoacid.
2. the biosynthesis associated protein of an oosporein, it is characterised in that the aminoacid sequence of described albumen
It is selected from the aminoacid sequence as shown in SEQ ID NO.:2-8.
3. the biosynthesis related genes of an oosporein, it is characterised in that described gene code claim
The biosynthesis associated protein of oosporein described in 2.
4. an expression vector, it is characterised in that the ovum spore that described expression vector contains described in claim 1 is mould
The biological synthesis gene cluster of element or its fragment, or the biosynthesis related genes of the oosporein described in claim 3.
5. the host cell of a restructuring, it is characterised in that described host cell contains described in claim 4
The biosynthesis gene of the oosporein described in claim 1 having external source is integrated on expression vector, or its chromosome
Bunch or claim 3 described in the biosynthesis related genes of oosporein.
6. a beauveria bassiana (Beauveria bassiana), it is characterised in that at described ball spore
In muscardine, in the biological synthesis gene cluster of oosporein, the one or more genes selected from lower group are deactivated:
OpS1, OpS3, OpS4, OpS5, OpS6, OpS7, thus do not produce oosporein.
7. a beauveria bassiana (Beauveria bassiana), in described beauveria bassiana, ovum spore
In the biological synthesis gene cluster of mycin, one or more genes are over-expressed, thus improve or recover oosporein
Yield,
Wherein, the described gene that is over-expressed is selected from lower group: OpS1, OpS3, OpS4, OpS5, OpS6
And OpS7.
8. an oosporein biosynthesis gene or the purposes of its albumen, it is characterised in that be used for synthesizing
The precursor of oosporein or intermediate, wherein said oosporein biosynthesis gene or its albumen are selected from down
Group: OpS1, OpS4, OpS5, OpS7.
9. the method preparing ooecium mycin, including step:
I (), in the condition of applicable cultivation and in the case of adding starting compound, is cultivated and is produced ooecium mycin
Host cell, thus produce ooecium mycin, wherein said starting compound is selected from lower group: orsellinic acid (Formulas I),
Compound 2 (Formula II), tetrahydroxy toluene (Formula V) or a combination thereof;With
(ii) isolated or purified goes out described ooecium mycin.
10. the method that host cell is transformed, it is characterised in that include step:
(a) measure each related gene belonging to ooecium mycin synthetic gene bunch in described host cell expression and/or
Activity;
B (), according to measurement result, imports the related gene of ooecium mycin synthetic gene bunch in described host cell,
Thus improve/recover described host cell and produce the ability of ooecium mycin,
Wherein, the related gene of described gene cluster include one or more following gene: OpS1, OpS3, OpS4,
OpS5, OpS6 or OpS7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510070362.2A CN105985967B (en) | 2015-02-10 | 2015-02-10 | Biological synthesis gene cluster of oosporins and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510070362.2A CN105985967B (en) | 2015-02-10 | 2015-02-10 | Biological synthesis gene cluster of oosporins and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105985967A true CN105985967A (en) | 2016-10-05 |
CN105985967B CN105985967B (en) | 2020-01-10 |
Family
ID=57041738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510070362.2A Expired - Fee Related CN105985967B (en) | 2015-02-10 | 2015-02-10 | Biological synthesis gene cluster of oosporins and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105985967B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113699130A (en) * | 2021-08-26 | 2021-11-26 | 中南民族大学 | Polyketide synthase PreuA-TEPreu3Construction of (A) and its application in preparation of nervonic acid |
CN116121083A (en) * | 2022-10-19 | 2023-05-16 | 西南大学 | Beauveria bassiana strain as a spawning sporulation and application thereof in synthesis of oosporine in CZB |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103421101A (en) * | 2013-08-31 | 2013-12-04 | 西南大学 | Gene knockout carrier of fungus C2H2 type zinc finger protein BbAzf and beauveria bassiana BbAzf |
-
2015
- 2015-02-10 CN CN201510070362.2A patent/CN105985967B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103421101A (en) * | 2013-08-31 | 2013-12-04 | 西南大学 | Gene knockout carrier of fungus C2H2 type zinc finger protein BbAzf and beauveria bassiana BbAzf |
Non-Patent Citations (4)
Title |
---|
FENG P.等: "Fungal biosynthesis of the bibenzoquinone oosporein to evade insect immunity", 《PNAS》 * |
GENBANK: "NCBI Reference Sequence: NW_007930867.1", 《GENBANK》 * |
胡丰林等: "一种白僵菌中MAO抑制剂的分离纯化和结构鉴定 ", 《菌物学报》 * |
胡丰林等: "一种白僵菌中MAO抑制剂的分离纯化和结构鉴定", 《菌物学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113699130A (en) * | 2021-08-26 | 2021-11-26 | 中南民族大学 | Polyketide synthase PreuA-TEPreu3Construction of (A) and its application in preparation of nervonic acid |
CN113699130B (en) * | 2021-08-26 | 2023-03-24 | 中南民族大学 | Polyketide synthase PreuA-TE Preu3 Construction of (A) and its application in preparation of nervonic acid |
CN116121083A (en) * | 2022-10-19 | 2023-05-16 | 西南大学 | Beauveria bassiana strain as a spawning sporulation and application thereof in synthesis of oosporine in CZB |
Also Published As
Publication number | Publication date |
---|---|
CN105985967B (en) | 2020-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Miao et al. | Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics | |
Li et al. | Towards understanding the biosynthetic pathway for ustilaginoidin mycotoxins in Ustilaginoidea virens | |
JP4642922B2 (en) | Pyripyropene A biosynthetic gene | |
CN102015756B (en) | NRPS-PKS gene cluster and its manipulation and utility | |
Heneghan et al. | The programming role of trans-acting enoyl reductases during the biosynthesis of highly reduced fungal polyketides | |
Meiser et al. | DKxanthene biosynthesis—Understanding the basis for diversity-oriented synthesis in myxobacterial secondary metabolism | |
CN103468625B (en) | Gene disruption mutant of streptomyces bingchenggensis as well as preparation method and application thereof | |
Donzelli et al. | Identification of a hybrid PKS–NRPS required for the biosynthesis of NG-391 in Metarhizium robertsii | |
CN1316001A (en) | Polyketides and their synthesis | |
Schneider et al. | Genome mining of Streptomyces sp. YIM 130001 isolated from lichen affords new thiopeptide antibiotic | |
CN103131716A (en) | Biosynthetic gene cluster of salinomycin and application thereof | |
TWI633190B (en) | Manufacturing method of bilipi edge | |
CN104974974A (en) | Saccharopolyspora spinosa high-pleocidin-yield engineering strain and application thereof | |
Elliott et al. | A gene cluster responsible for biosynthesis of phomenoic acid in the plant pathogenic fungus, Leptosphaeria maculans | |
CN105985967A (en) | Biosynthetic gene cluster of oosporein and application of biosynthetic gene cluster | |
CN103820474A (en) | Biosynthesis gene cluster of polyenoid and polyol macrolide compound | |
US11655477B2 (en) | Methods for thaxtomin production and engineered non-native Streptomyces with increased thaxtomin production | |
CN104911196A (en) | Trioxacarcin biosynthetic gene cluster and application thereof | |
CN102260644B (en) | Mutant strain of Streptomyces flaveolus and construction method and application thereof | |
CN104427870A (en) | Uk-2 biosynthetic genes and method for improving uk-2 productivity using same | |
CN101545000B (en) | Method for improving yield of ECO-0501 produced by fermenting Amycolatopsis orientalis | |
RU2236463C2 (en) | Polynucleotide eliciting ability to accelerate biosynthesis of pravastatin precursor ml-236b (variants), plasmid expression vector, strain penicillium citrinum (variants), strain escherichia coli (variants), polypeptide accelerating biosynthesis of ml-236b (variants), pravastatin precursor ml-236b, method for preparing pravastatin | |
CN104164399B (en) | The superior strain and its construction method of cyclic ester peptide antibiotics Hei Motading | |
CN102010871A (en) | Biosynthesis gene cluster of xantholipin | |
CN114561405B (en) | Application of synthetic gene cluster of trichoderma Harzianolide in preparation of preparation for improving plant gray mold resistance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200506 Address after: 200032 building 4, No. 300 Fenglin Road, Xuhui District, Shanghai Patentee after: Center for excellence and innovation in molecular plant science, Chinese Academy of Sciences Address before: 200031 Yueyang Road, Shanghai, No. 319, No. Patentee before: SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200110 |
|
CF01 | Termination of patent right due to non-payment of annual fee |